- Conditions
- Acute Stroke, Endovascular Thrombectomy
- Interventions
- Nicardipine, Labetalol, Hydralazine
- Drug
- Lead sponsor
- University of Cincinnati
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2022
- U.S. locations
- 3
- States / cities
- Hartford, Connecticut • Cincinnati, Ohio • Nashville, Tennessee
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 26
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Stroke
- Interventions
- Pre-pandemic stroke related metrics, Stroke related metrics during the pandemic
- Other
- Lead sponsor
- Boston Medical Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 345,089 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021
- U.S. locations
- 2
- States / cities
- Atlanta, Georgia • Boston, Massachusetts
- Conditions
- Acute Ischemic Stroke
- Interventions
- Intra-arterial Tenecteplase, Intra-arterial Saline
- Drug
- Lead sponsor
- Wake Forest University Health Sciences
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Charlotte, North Carolina
- Conditions
- Brain Stroke, Stenting Treatment, Acute Ischemic Stroke
- Interventions
- Mechanical Thrombectomy plus adjunct stenting, Mechanical Thrombectomy
- Procedure · Device
- Lead sponsor
- ProMedica Health System
- Other
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 342 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2030
- U.S. locations
- 1
- States / cities
- Toledo, Ohio
- Conditions
- Ischemic Stroke, Blood Pressure
- Interventions
- Phenylephrine, Norepinephrine
- Drug
- Lead sponsor
- Yale University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2026
- U.S. locations
- 1
- States / cities
- New Haven, Connecticut
- Conditions
- Acute Lower Limb Arterial Occlusion
- Interventions
- Artix Thrombectomy System
- Device
- Lead sponsor
- Inari Medical
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 250 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2029
- U.S. locations
- 14
- States / cities
- New Haven, Connecticut • Washington D.C., District of Columbia • Boston, Massachusetts + 11 more
- Conditions
- Acute Ischemic Stroke
- Interventions
- J147 Emulsion for Injection, Placebo
- Drug · Other
- Lead sponsor
- Abrexa Pharmaceuticals, Inc.
- Industry
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 196 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- Austin, Texas
- Conditions
- Stroke, Acute, Cerebral Infarction
- Interventions
- Endovascular Thrombectomy, Trevo Retriever, Solitaire™ FR Revascularization Device, Penumbra thrombectomy system, Covidien MindFrame Capture Revascularization Device
- Procedure · Device
- Lead sponsor
- Gregory W Albers
- Other
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 182 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2017
- U.S. locations
- 40
- States / cities
- Birmingham, Alabama • Fresno, California • La Jolla, California + 26 more
- Conditions
- Acute Ischemic Stroke
- Interventions
- Endovascular Thrombectomy, Medical Management
- Device · Other
- Lead sponsor
- University Hospitals Cleveland Medical Center
- Other
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 352 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2023
- U.S. locations
- 19
- States / cities
- Los Angeles, California • Jacksonville, Florida • Chicago, Illinois + 14 more
- Conditions
- Stroke, Acute
- Interventions
- Nerinetide (NA-1), 2.6 mg/kg, Placebo
- Drug
- Lead sponsor
- NoNO Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,105 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 20
- States / cities
- Los Angeles, California • San Francisco, California • Torrance, California + 17 more
- Conditions
- Acute Ischemic Stroke (AIS)
- Interventions
- Placebo, scp776 (1.9 mg/kg), scp776 (3.8 mg/kg), scp776 (4.8 mg/kg), scp776 (all dose levels)
- Drug
- Lead sponsor
- Silver Creek Pharmaceuticals
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 120 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2025
- U.S. locations
- 22
- States / cities
- Scottsdale, Arizona • Tucson, Arizona • Hartford, Connecticut + 18 more
- Conditions
- Ischemic Stroke
- Interventions
- Experimental: endovascular thrombectomy in patients who suffer a distal medium vessel occlusion, Standard medical management
- Device · Other
- Lead sponsor
- Raul Nogueira
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 584 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 4
- States / cities
- Atlanta, Georgia • Iowa City, Iowa • Toledo, Ohio + 1 more
- Conditions
- Ischemic Stroke
- Interventions
- Endovascular thrombectomy with any FDA-approved category POL or NRY device, Medical Management
- Device · Other
- Lead sponsor
- Medical University of South Carolina
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 1,600 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2030
- U.S. locations
- 41
- States / cities
- Birmingham, Alabama • La Jolla, California • Los Angeles, California + 34 more
- Conditions
- Stroke, Acute, Ischemic Stroke, Acute
- Interventions
- EndovascularThrombectomy, Endovascular thrombectomy with any FDA-approved device
- Procedure · Device
- Lead sponsor
- Stanford University
- Other
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 1
- States / cities
- Palo Alto, California
- Conditions
- Acute Ischemic Stroke
- Interventions
- Thrombectomy
- Procedure
- Lead sponsor
- University of Missouri-Columbia
- Other
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 72 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2021
- U.S. locations
- 1
- States / cities
- Columbia, Missouri
- Conditions
- Acute Ischemic Stroke
- Interventions
- Endovascular Thrombectomy, Medical Management
- Device · Other
- Lead sponsor
- Amrou Sarraj
- Other
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 408 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2029
- U.S. locations
- 6
- States / cities
- Chicago, Illinois • Kansas City, Kansas • St Louis, Missouri + 3 more
- Conditions
- Ischemic Stroke
- Interventions
- Tigertriever revascularization device
- Device
- Lead sponsor
- Rapid Medical
- Industry
- Eligibility
- 18 Years to 85 Years
- Enrollment
- 160 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2020
- U.S. locations
- 16
- States / cities
- Los Angeles, California • Thousand Oaks, California • Coral Springs, Florida + 12 more
- Conditions
- Acute Ischemic Stroke
- Interventions
- LT3001 Drug Product, Placebo
- Drug
- Lead sponsor
- Lumosa Therapeutics Co., Ltd.
- Industry
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 66 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 1
- States / cities
- Chattanooga, Tennessee
- Conditions
- Stroke, Acute
- Interventions
- Placebo, Nerinetide
- Drug
- Lead sponsor
- NoNO Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 850 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2023
- U.S. locations
- 17
- States / cities
- Phoenix, Arizona • Torrance, California • Englewood, Colorado + 14 more
- Conditions
- Pulmonary Embolism
- Interventions
- Hēlo PE Thombectomy System
- Device
- Lead sponsor
- Endovascular Engineering
- Industry
- Eligibility
- 18 Years to 90 Years
- Enrollment
- 177 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 21
- States / cities
- Los Angeles, California • Pasadena, California • Torrance, California + 13 more
- Conditions
- Acute Ischemic Stroke
- Interventions
- endovascular thrombectomy (EVT), Standarad medical care
- Device · Other
- Lead sponsor
- Dr. Michael D Hill
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 530 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2026
- U.S. locations
- 20
- States / cities
- Little Rock, Arkansas • San Francisco, California • Torrance, California + 14 more
- Conditions
- Stroke, Ischemic
- Interventions
- RNS60, Placebo
- Drug
- Lead sponsor
- Revalesio Corporation
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 83 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 7
- States / cities
- Chicago, Illinois • Portland, Oregon • Philadelphia, Pennsylvania + 3 more
- Conditions
- Acute Stroke
- Interventions
- Acute Endovascular Stroke Treatment
- Other
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 191 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2019
- U.S. locations
- 4
- States / cities
- New York, New York
- Conditions
- Acute Ischemic Stroke
- Interventions
- Intravenous (IV) recombinant human tissue plasminogen activator (rtPA), Solitaire revascularization device
- Drug · Device
- Lead sponsor
- Medtronic Neurovascular Clinical Affairs
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 196 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2015
- U.S. locations
- 1
- States / cities
- Buffalo, New York